What is the estimated Glomerular Filtration Rate (GFR) in a 74-year-old hypertensive male with a creatinine level of 89?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Estimated GFR for a 74-Year-Old Hypertensive Male with Creatinine 89

The estimated glomerular filtration rate (eGFR) for a 74-year-old hypertensive male with creatinine of 89 μmol/L is approximately 70-75 mL/min/1.73 m², which places him in Stage 2 Chronic Kidney Disease (mild decrease in GFR).

Calculation of eGFR

The eGFR can be calculated using several formulas:

  1. Cockcroft-Gault Formula 1:

    • Formula: [(140 - age) × weight] / [72 × SCr] × (0.85 if female)
    • For a 74-year-old male with creatinine of 89 μmol/L (1.01 mg/dL), assuming average weight
    • This would yield approximately 70-75 mL/min (varies based on weight)
  2. MDRD Equation 2:

    • More accurate than serum creatinine alone
    • Takes into account age, gender, race, and serum creatinine
    • Would yield similar results for this patient

Interpretation of eGFR Results

According to the National Kidney Foundation classification system 1, 2:

Stage Description GFR (mL/min/1.73 m²)
1 Kidney damage with normal or increased GFR ≥90
2 Mild decrease in GFR 60-89
3a Mild to moderate decrease in GFR 45-59
3b Moderate to severe decrease in GFR 30-44
4 Severe decrease in GFR 15-29
5 Kidney failure <15 or dialysis

With an eGFR of approximately 70-75 mL/min/1.73 m², this patient falls into Stage 2 CKD (mild decrease in GFR).

Important Considerations

  • Age-related decline: Some degree of GFR decline is physiologically normal with aging 3. For a 74-year-old, an eGFR of 70-75 mL/min/1.73 m² represents a relatively well-preserved kidney function.

  • Hypertension impact: Hypertension is a risk factor for progressive kidney damage 1. This patient should have careful blood pressure management to preserve kidney function.

  • Diagnosis limitations: Stage 2 CKD diagnosis requires evidence of kidney damage (such as albuminuria) in addition to the GFR value 2. The creatinine level alone is insufficient for complete CKD staging.

  • Monitoring recommendations: For a hypertensive patient with this eGFR:

    • Regular monitoring of kidney function every 3-6 months
    • Blood pressure target of <130/80 mmHg 2
    • Screening for albuminuria to assess kidney damage

Clinical Implications

  1. Medication adjustments: Most medications do not require dose adjustment at this level of kidney function 1, but careful monitoring is still warranted.

  2. Cardiovascular risk: Even mild reductions in GFR increase cardiovascular risk, especially in the context of hypertension 1.

  3. Progression risk: The combination of age and hypertension puts this patient at risk for progressive decline in kidney function, requiring regular monitoring.

Pitfalls to Avoid

  • Relying solely on serum creatinine: Serum creatinine alone is a poor indicator of kidney function, especially in elderly patients where muscle mass is reduced 1.

  • Ignoring age-related changes: Normal GFR values decrease with age, and values below 60 mL/min/1.73 m² may be physiologically normal in adults older than 70 years 3.

  • Missing albuminuria assessment: Complete kidney function assessment requires evaluation of both GFR and albuminuria 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Kidney Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Normal reference values for glomerular filtration rate: what do we really know?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.